Marjanović Ivan, Tomić Aleksandar, Marić Nebojša, Pecarski Danijela, Šarac Momir, Paunović Dragana, Rusović Siniša
Vojnosanit Pregl. 2016 Oct;73(10):941-4. doi: 10.2298/VSP150420091M.
We present our first experience with endovascular treatment of 6 subclavian artery aneurysms (SAA) occurring in five male and one female patient. All patients, in our studies, according to ASA classification were high risk for open repair of SAA. The etiology of the all aneurysms was atherosclerosis degeneration of the artery. Two aneurysms were of intrathoracic location, then the other were extrathoracic. Symptoms related to subclavian artery aneurysms were present in two patients, compression and chest pain in one, and hemorrhage shock in second, while the remaining patients were asymptomatic. We preferred the Viabhan endoprosthesis for endovascular repair in 5 cases. In one patient with ruptured of subclavian artery aneurysm who was high-risk for open repair we made combined endovascular procedure. First at all, we covered the origin of left subclavian artery with thoracic stent graft and after that we put two coils in proximal part of subclavian artery. There was no operative mortality, and the early patency rate was 100%. The follow-up period was from 3 months to 3 years. During this period, one patient died of heart failure and one patient required endovascular reoperation due to endoleak type I. Endovascular treatment is recommended for all patients with subclavian artery aneurysm whenever this is possible due to anatomical reasons especially in high-risk patient with intrathoracic localization of aneurysm, to prevent potential complications.
我们介绍了对5名男性和1名女性患者发生的6例锁骨下动脉瘤(SAA)进行血管内治疗的首次经验。在我们的研究中,根据美国麻醉医师协会(ASA)分类,所有患者进行SAA开放修复的风险都很高。所有动脉瘤的病因都是动脉粥样硬化退变。2例动脉瘤位于胸内,其余位于胸外。2例患者出现了与锁骨下动脉瘤相关的症状,1例有压迫感和胸痛,另1例有出血性休克,其余患者无症状。5例患者我们首选Viabhan血管内假体进行血管内修复。1例锁骨下动脉瘤破裂且开放修复风险高的患者,我们进行了联合血管内手术。首先,我们用胸主动脉覆膜支架覆盖左锁骨下动脉的起始部,然后在锁骨下动脉近端放置了两个弹簧圈。无手术死亡病例,早期通畅率为100%。随访期为3个月至3年。在此期间,1例患者死于心力衰竭,1例患者因I型内漏需要进行血管内再次手术。只要解剖条件允许,对于所有锁骨下动脉瘤患者,尤其是动脉瘤位于胸内的高危患者,建议进行血管内治疗,以预防潜在并发症。